Azitra (AZTR) Other Non Operating Income (2022 - 2026)
Azitra (AZTR) reported Other Non Operating Income of -$4624.0 for Q1 2026, down 12.21% on a YoY basis from -$5266.9 in Q1 2025, and up 22.31% quarter-over-quarter from -$5952.0 in Q4 2025.
Azitra (AZTR) Other Non Operating Income (2022 - 2026) Analysis & Trends
Azitra has reported Other Non Operating Income for 5 years, with the latest figure at -$4624.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 12.21% year-over-year to -$4624.0; the trailing twelve-month figure through Mar 2026 stood at -$43892.0 (down 354.89% YoY), and the FY2025 full-year result was -$43389.0, down 388.99% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$4624.0, up from -$5952.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $198234.0 in Q2 2022, with the low at -$47542.0 in Q3 2023.
- Historically, Other Non Operating Income has averaged $6975.2 across 5 years, with a median of -$2902.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Non Operating Income surged 828.09% — and 2025, when it tumbled 443.04%.
- Azitra's Other Non Operating Income stood at $20014.0 in 2022, then sank by 102.95% to -$591.0 in 2023, then surged by 828.09% to $4303.0 in 2024, then slumped by 238.32% to -$5952.0 in 2025, then gained by 22.31% to -$4624.0 in 2026.
- The last three Other Non Operating Income figures came in at -$4624.0 (Q1 2026), -$5952.0 (Q4 2025), and -$628.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,624.00 |
| Dec 31, 2025 | -5,952.00 |
| Sep 30, 2025 | -628.00 |
| Jun 30, 2025 | -32,688.00 |
| Mar 31, 2025 | -4,121.00 |
| Dec 31, 2024 | 4,303.00 |
| Sep 30, 2024 | 7,509.00 |
| Jun 30, 2024 | 9,529.00 |
| Mar 31, 2024 | -6,327.00 |
| Dec 31, 2023 | -591.00 |
| Sep 30, 2023 | -47,542.00 |
| Jun 30, 2023 | -1,683.00 |
| Mar 31, 2023 | -4,792.00 |
| Dec 31, 2022 | 20,014.00 |
| Sep 30, 2022 | -19,038.00 |
| Jun 30, 2022 | 198,234.00 |